Together, our computational pipeline highlights PEP8 and PEP44 as promising κ-casein-derived inhibitors of GSK-3β, illustrating a rational design of food-derived peptides as potential multifunctional candidates for Alzheimer's disease. The gene discussed is GSK3B; the disease is early-onset autosomal dominant Alzheimer disease.